Carlos

GSK gets it

Post author:Carlos
Post published:July 26, 2011
Post category:Emerging Markets Europe Pharmaceutical
Post comments:0 Comments

As FiercePharma correctly points out, GSK's Q II report reflects the overall industry trends quite accurately: The rest of Glaxo's report, like the rest of Big Pharma's Q2 results so…

Looking for a job in pharma? Good luck

Post author:Carlos
Post published:July 14, 2011
Post category:Biotech Drug Delivery Drug Development Mergers & Acquisitions
Post comments:0 Comments

Today, KPMG is reporting results from a survey of pharmaceutical executives. In this survey, respondents said they will increase their acquisition activity in the coming year in order to gain…

All you need is…guts

Post author:Carlos
Post published:July 11, 2011
Post category:Drug Development Entrepreneurship Pharmaceutical

Luke Timmerman at Xconomy wrote a provocative piece today entitled The Missing Ingredient in Today's Biotech: Guts. His thesis is that the industry is so paralyzed by fear and insecurity that it lacks…

BIO Convention and Business Socialization

Post author:Carlos
Post published:July 7, 2011
Post category:Conferences Social Media
Post comments:1 Comment

We previously posted our comments on BIO 2011. However, one aspect of the conference that really stood out was the use of social media. Attendees were encouraged to provide links…

Observations from BIO 2011

Post author:Carlos
Post published:July 6, 2011
Post category:Conferences Uncategorized
Post comments:2 Comments

The Lacerta Bio team attended the annual BIO Convention in Washington, DC last week. BIO has become one of the key conventions for pharma/biotech business development, and is a "must…

Dear Pharma, What Went Wrong?

Post author:Carlos
Post published:June 23, 2011
Post category:Drug Development Pharmaceutical

The pharmaceutical industry has benefitted mankind by developing life-saving and life-sustaining drugs. However, recent turmoils have led many to question the value provided by the industry. Matt Herper tackles these complex issues across two blog posts.

Is deal-making becoming more difficult?

Post author:Carlos
Post published:June 20, 2011
Post category:Biotech Drug Development Pharmaceutical

The June, 2011 issue of Nature Drug Discovery has a interesting short article based on a survey conducted by our good friends at PharmaVentures. The authors surveyed 180 business development…

Sandwich Shoppe For Sale

Post author:Carlos
Post published:June 14, 2011
Post category:Pharmaceutical

We posted in February the news that Pfizer was closing their large R&D facility in Kent, UK. It was with some surprise that we learn that the facility is already…

The SmartCells Story

Post author:Carlos
Post published:June 13, 2011
Post category:Biotech Drug Development Outsourcing Venture Capital

Bruce Booth from Atlas Ventures has a fascinating story on his blog. We won't steal Bruce's thunder. Instead, we encourage you to read it there first. The gist of the story is…

The Era of the One Man Pharma Band (With Updates)

Post author:Carlos
Post published:May 31, 2011
Post category:Biotech CRO Outsourcing Pharmaceutical Venture Capital

There is a fascinating discussion taking place over at Derek Lowe's blog today on one-man drug companies: ...some of them are not quite down to one person, but you can…

Get in touch